Investment Q&A

• WELL Health Technologies Corp. (WELL $5.19)
  • $5.19 Cap: $1.46B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: Well used the word "partnership" with Microsoft in the release, although it sounds like they are simply using Microsoft products?

Upvote 6

Read Answer Asked by Charles on May 01, 2024

• CVS Health Corporation (CVS $77.90)
  • $77.90 P/E (TTM): 21.46X Cap: $98.80B
  • View CVS Profile
  • View Questions on CVS

Q: Would you add to a small position in a dividend portfolio with this drop?

Upvote 1

Read Answer Asked by Gregory on May 01, 2024

• Bristol-Myers Squibb Company (BMY $43.96)
  • $43.96 P/E (TTM): 17.89X Cap: $90.94B
  • View BMY Profile
  • View Questions on BMY

Q: Why it keeps falling?
Would you buy it?

Thanks,
Milan

Upvote 2

Read Answer Asked by Milan on April 30, 2024

• Zoetis Inc. Class A (ZTS $141.11)
  • $141.11 P/E (TTM): 24.7X Cap: $63.54B
  • View ZTS Profile
  • View Questions on ZTS

Q: Hi,
Long time share holder of Zoetis with a current portfolio weight of 2%. With this pull back is it a good opportunity to add? Or do you feel it is still expensive with the risks of medication side effects affecting business?
Thanks,
Kerri

Upvote 2

Read Answer Asked by KERRI on April 30, 2024

• Gilead Sciences Inc. (GILD $117.18)
  • $117.18 P/E (TTM): 23.21X Cap: $145.39B
  • View GILD Profile
  • View Questions on GILD

Q: May I have your comments on Gilead's 1st. Quarter Results and view on this continuing as a Hold. Thanks Gerry.

Upvote 1

Read Answer Asked by Gerry on April 29, 2024

• Illumina Inc. (ILMN $93.86)
  • $93.86 P/E (TTM): 12.4X Cap: $14.42B
  • View ILMN Profile
  • View Questions on ILMN

Q: What is the expressions for Ilmn? And if they match expressions would it be a ok time to dip a toe in for a half position?

Upvote 2

Read Answer Asked by Mark on April 25, 2024

• Sernova Biotherapeutics Inc. (SVA $0.17)
  • $0.17 Cap: $55M
  • View SVA Profile
  • View Questions on SVA

Q: Your comments on SVA. Is it a Hold or a Sell? Thanks

Upvote 1

Read Answer Asked by Charles on April 25, 2024

• IntelGenx Technologies Corp. (IGX $0.24)
  • $0.24 Cap: $41M
  • View IGX Profile
  • View Questions on IGX

Q: Your updated thoughts on IGX. Would you consider it a Buy, Sell, or Hold? Thanks

Upvote 1

Read Answer Asked by Charles on April 24, 2024

• Eli Lilly and Company (LLY $833.49)
  • $833.49 P/E (TTM): 55.28X Cap: $809.55B
  • View LLY Profile
  • View Questions on LLY
• Viemed Healthcare Inc. (VMD $6.82)
  • $6.82 P/E (TTM): 20.21X Cap: $272M
  • View VMD Profile
  • View Questions on VMD
• Vitalhub Corp. (VHI $10.87)
  • $10.87 P/E (TTM): 134.24X Cap: $609M
  • View VHI Profile
  • View Questions on VHI
  • View Reports on VHI
• WELL Health Technologies Corp. (WELL $5.19)
  • $5.19 Cap: $1.46B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: Good evening,

I currently own VMD, VHI, LLY, and WELL. I'm considering a consolidation down to three of the four stocks. For a five-year hold, how might you rank these in terms of overall growth potential and risk? Thanks, Brad

Upvote 7

Read Answer Asked by Bradley on April 24, 2024

• Intuitive Surgical Inc. (ISRG $429.59)
  • $429.59 P/E (TTM): 62.41X Cap: $153.99B
  • View ISRG Profile
  • View Questions on ISRG
• Abbott Laboratories (ABT $132.57)
  • $132.57 P/E (TTM): 16.73X Cap: $230.73B
  • View ABT Profile
  • View Questions on ABT
• Danaher Corporation (DHR $202.46)
  • $202.46 P/E (TTM): 43.41X Cap: $144.97B
  • View DHR Profile
  • View Questions on DHR
• Eli Lilly and Company (LLY $833.49)
  • $833.49 P/E (TTM): 55.28X Cap: $809.55B
  • View LLY Profile
  • View Questions on LLY
• UnitedHealth Group Incorporated (DE) (UNH $354.50)
  • $354.50 P/E (TTM): 16.02X Cap: $321.06B
  • View UNH Profile
  • View Questions on UNH
• Novo Nordisk A/S (NVO $56.93)
  • $56.93 P/E (TTM): 16.76X Cap: $363.68B
  • View NVO Profile
  • View Questions on NVO
• iShares Global Healthcare ETF (IXJ $90.88)
  • $90.88 P/E (TTM): 25.66X Cap: $4.01B
  • View IXJ Profile
  • View Questions on IXJ
• Align Technology Inc. (ALGN $125.79)
  • $125.79 P/E (TTM): 22.41X Cap: $9.55B
  • View ALGN Profile
  • View Questions on ALGN
• Health Care Select Sector SPDR (XLV $142.11)
  • $142.11 P/E (TTM): 23.15X Cap: $35.85B
  • View XLV Profile
  • View Questions on XLV
• iShares U.S. Healthcare ETF (IYH $59.87)
  • $59.87 P/E (TTM): 22.94X Cap: $2.91B
  • View IYH Profile
  • View Questions on IYH

Q: Please recommend a few health care investments.

Upvote 6

Read Answer Asked by Susan on April 19, 2024

• Intuitive Surgical Inc. (ISRG $429.59)
  • $429.59 P/E (TTM): 62.41X Cap: $153.99B
  • View ISRG Profile
  • View Questions on ISRG
• Vertex Pharmaceuticals Incorporated (VRTX $407.79)
  • $407.79 P/E (TTM): 29.85X Cap: $106.36B
  • View VRTX Profile
  • View Questions on VRTX
• Danaher Corporation (DHR $202.46)
  • $202.46 P/E (TTM): 43.41X Cap: $144.97B
  • View DHR Profile
  • View Questions on DHR
• Johnson & Johnson (JNJ $190.72)
  • $190.72 P/E (TTM): 20.29X Cap: $460.18B
  • View JNJ Profile
  • View Questions on JNJ
• Eli Lilly and Company (LLY $833.49)
  • $833.49 P/E (TTM): 55.28X Cap: $809.55B
  • View LLY Profile
  • View Questions on LLY
• Align Technology Inc. (ALGN $125.79)
  • $125.79 P/E (TTM): 22.41X Cap: $9.55B
  • View ALGN Profile
  • View Questions on ALGN

Q: I've held JNJ for over 15 years based on my belief in the quality of their management. I'm feeling my trust may now be overly 'generous' and it may be time to move on, particularly now that the steadiness of consumer products is gone. I'm considering VRTX or another suggestion you could offer. I have full positions in TMO, SYK and UNH, highlighting my preference for quality.

Upvote 8

Read Answer Asked by Mike on April 19, 2024

• Quipt Home Medical Corp. (QIPT $3.37)
  • $3.37 Cap: $152M
  • View QIPT Profile
  • View Questions on QIPT

Q: Why does QIPT keep hitting 52 week lows? Their recent earnings appeared to be decent. Is it time to sell this one?

Upvote 1

Read Answer Asked by Walter on April 18, 2024

• WELL Health Technologies Corp. (WELL $5.19)
  • $5.19 Cap: $1.46B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: Could you provide the forward earnings estimated for 2024 and the broken down in quarters.

thanks

Upvote 4

Read Answer Asked by Daniel on April 17, 2024

• WELL Health Technologies Corp. (WELL $5.19)
  • $5.19 Cap: $1.46B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: Hi 5i, trying to find a rose amongst thorns, and given the change in inclusion rates due to the budget, wouldn't this accelerate any deals in the pipeline? Not trying to be political.

#16Months2GO

Upvote 2

Read Answer Asked by Christopher on April 17, 2024

• UnitedHealth Group Incorporated (DE) (UNH $354.50)
  • $354.50 P/E (TTM): 16.02X Cap: $321.06B
  • View UNH Profile
  • View Questions on UNH

Q: Hi Team,

Can I please have your comments on UNH's recent earnings. Also is it now a buy, sell or hold and your rationales?
Thanks
Harry

Upvote 4

Read Answer Asked by Harry on April 17, 2024

• WELL Health Technologies Corp. (WELL $5.19)
  • $5.19 Cap: $1.46B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: It is good to see WELL make an acquisition. How significant is this deal ?

Upvote 4

Read Answer Asked by Clarence on April 17, 2024

• WELL Health Technologies Corp. (WELL $5.19)
  • $5.19 Cap: $1.46B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: When do they report first quarter results?

Upvote 2

Read Answer Asked by Robert on April 16, 2024

• WELL Health Technologies Corp. (WELL $5.19)
  • $5.19 Cap: $1.46B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL
• HealWELL AI Inc. Class A Subordinate Voting Shares (AIDX $1.41)
  • $1.41 Cap: $432M
  • View AIDX Profile
  • View Questions on AIDX

Q: Healwell is tremendously appreciating in share price. How does Well health tech. benefit from this. I don't know if they have an investment, part ownership or if its just a collaboration.

Thanks Steve

Upvote 8

Read Answer Asked by Steve on April 15, 2024

• Medicus Pharma Ltd. (MDCX)
  • Cap: $90M
  • View MDCX Profile
  • View Questions on MDCX

Q: They have the only non invasive basal cell carcinoma treatment at the moment that is effective as a cure. They found this out after the phase 1 safety and tolerabiliy study. No side effects. Does this look like a good opportunity for investment even though it is very early in clinical trials. This kind of investment is usually high risk but it seems mitigated.

Upvote 2

Read Answer Asked by Steve on April 15, 2024

• Zoetis Inc. Class A (ZTS $141.11)
  • $141.11 P/E (TTM): 24.7X Cap: $63.54B
  • View ZTS Profile
  • View Questions on ZTS

Q: Good morning,

Can you shed some light on Zoetis' decline this am?

Thank you.

Upvote 2

Read Answer Asked by Brad on April 13, 2024